Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydroxyapatite cement in pediatric craniofacial reconstruction.

Lisa David1, Louis Argenta, David Fisher

  • 1Department of Plastic Surgery, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157-1075, USA. ldavid@wfubmc.edu

The Journal of Craniofacial Surgery
|February 9, 2005
PubMed
Summary

Hydroxyapatite cement shows promise as a safe and effective alternative to autogenous bone for pediatric craniofacial reconstruction. This bone substitute offers good biocompatibility and infection resistance, avoiding donor site morbidity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Facilitating access to clinical data from a randomized controlled trial of complex adaptive design.

BMC research notes·2026
Same author

Beyond Viral Control: Tenofovir's Hidden Impact on Blood-Brain Barrier Endothelial Cells.

Microcirculation (New York, N.Y. : 1994)·2026
Same author

A Phase I Study of Copanlisib and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Clinical lymphoma, myeloma & leukemia·2026
Same author

Chitosan-hyaluronic acid engineered polycaprolactone nanoparticles enhance curcumin antiplasmodial activity and preserve blood-brain barrier integrity.

Journal of biomaterials science. Polymer edition·2026
Same author

Development of a prediction model for acute kidney injury in critically ill patients with advanced colorectal cancer based on white blood cell-related indicators.

Frontiers in oncology·2026
Same author

Progressive Hypoxia Exacerbates Breast Cancer Metastasis by Paracrine Modulation of the Blood-brain Barrier Endothelium.

Journal of molecular neuroscience : MN·2026

Area of Science:

  • Craniofacial Surgery
  • Biomaterials Science
  • Pediatric Orthopedics

Background:

  • Autogenous bone grafts are the standard for cranial defect repair but have limitations.
  • These limitations include donor site morbidity, increased operative time, blood loss, and limited graft quantity.
  • Hydroxyapatite cements offer an alternative bone substitute, but their use in growing pediatric skulls is restricted.

Purpose of the Study:

  • To evaluate the safety and long-term efficacy of hydroxyapatite cement for pediatric craniofacial bone defect repair.
  • Assess biocompatibility, infection resistance, structural integrity, volume stability, aesthetics, and integration in growing skulls.
  • Determine if hydroxyapatite cement is a viable alternative to autogenous bone in pediatric patients.

Main Methods:

Related Experiment Videos

  • Retrospective review of pediatric patients undergoing craniofacial reconstruction with hydroxyapatite cement.
  • Study period: May 1997 to March 2001.
  • Eight patients (11 operations) aged 25-100 months followed for 23-72 months.

Main Results:

  • No mortalities or significant morbidities observed in the study population.
  • Hydroxyapatite cement demonstrated biocompatibility and resistance to infection in non-sinus sites.
  • The material was found to be a suitable alternative to autogenous bone for pediatric craniofacial reconstruction.

Conclusions:

  • Hydroxyapatite cement is a safe and effective alternative to autogenous bone for pediatric craniofacial reconstruction.
  • It offers advantages by eliminating donor site morbidity and graft quantity limitations.
  • The bone substitute shows good biocompatibility and infection resistance in appropriate surgical sites.